These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 28415828)

  • 1. Melatonin for the prevention and treatment of cancer.
    Li Y; Li S; Zhou Y; Meng X; Zhang JJ; Xu DP; Li HB
    Oncotarget; 2017 Jun; 8(24):39896-39921. PubMed ID: 28415828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emergence of melatonin in oncology: Focus on colorectal cancer.
    Gil-Martín E; Egea J; Reiter RJ; Romero A
    Med Res Rev; 2019 Nov; 39(6):2239-2285. PubMed ID: 30950095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin and its ubiquitous anticancer effects.
    Bhattacharya S; Patel KK; Dehari D; Agrawal AK; Singh S
    Mol Cell Biochem; 2019 Dec; 462(1-2):133-155. PubMed ID: 31451998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic actions of melatonin in cancer: possible mechanisms.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review on Melatonin's Effects in Cancer: Potential Mechanisms.
    Hanikoglu A; Kucuksayan E; Akduman RC; Ozben T
    Anticancer Agents Med Chem; 2018; 18(7):985-992. PubMed ID: 29173185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MT1 melatonin receptors and their role in the oncostatic action of melatonin].
    Danielczyk K; Dziegiel P
    Postepy Hig Med Dosw (Online); 2009 Sep; 63():425-34. PubMed ID: 19837985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy.
    Witt-Enderby PA; Radio NM; Doctor JS; Davis VL
    J Pineal Res; 2006 Nov; 41(4):297-305. PubMed ID: 17014686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of melatonin in prevention and treatment of leukaemia.
    Ng MG; Ng KY; Koh RY; Chye SM
    Horm Mol Biol Clin Investig; 2021 Aug; 42(4):445-461. PubMed ID: 34355548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities.
    Talib WH; Alsayed AR; Abuawad A; Daoud S; Mahmod AI
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33923028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of androgen-sensitive LNCaP prostate cancer growth in vivo by melatonin: association of antiproliferative action of the pineal hormone with mt1 receptor protein expression.
    Xi SC; Siu SW; Fong SW; Shiu SY
    Prostate; 2001 Jan; 46(1):52-61. PubMed ID: 11170132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin as a treatment for gastrointestinal cancer: a review.
    Xin Z; Jiang S; Jiang P; Yan X; Fan C; Di S; Wu G; Yang Y; Reiter RJ; Ji G
    J Pineal Res; 2015 May; 58(4):375-87. PubMed ID: 25752643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatic action of melatonin: facts and question marks.
    Pawlikowski M; Winczyk K; Karasek M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():24-9. PubMed ID: 12019348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin: A Potential Therapeutic Option for Breast Cancer.
    Kong X; Gao R; Wang Z; Wang X; Fang Y; Gao J; Reiter RJ; Wang J
    Trends Endocrinol Metab; 2020 Nov; 31(11):859-871. PubMed ID: 32893084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Oncostatic Effects of Melatonin against Prostate Cancer.
    Samanta S
    Crit Rev Oncog; 2021; 26(3):53-67. PubMed ID: 35377986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of melatonin membrane receptors increases calcium-binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms.
    Das A; Wallace G; Reiter RJ; Varma AK; Ray SK; Banik NL
    J Pineal Res; 2013 Jan; 54(1):58-68. PubMed ID: 22823500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of melatonin treatment in primary culture of canine mammary tumors.
    Lopes JR; Maschio LB; Jardim-Perassi BV; Moschetta MG; Ferreira LC; Martins GR; Gelaleti GB; De Campos Zuccari DA
    Oncol Rep; 2015 Jan; 33(1):311-9. PubMed ID: 25384569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro.
    Winczyk K; Fuss-Chmielewska J; Lawnicka H; Pawlikowski M; Karasek M
    Neuro Endocrinol Lett; 2009; 30(5):657-62. PubMed ID: 20035258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms Underlying Tumor Suppressive Properties of Melatonin.
    Bondy SC; Campbell A
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30060531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of melatonin receptors in murine pancreatic islets.
    Nagorny CL; Sathanoori R; Voss U; Mulder H; Wierup N
    J Pineal Res; 2011 May; 50(4):412-7. PubMed ID: 21355877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two neuroendocrine G protein-coupled receptor molecules, somatostatin and melatonin: Physiology of signal transduction and therapeutic perspectives.
    Costanzi E; Simioni C; Conti I; Laface I; Varano G; Brenna C; Neri LM
    J Cell Physiol; 2021 Apr; 236(4):2505-2518. PubMed ID: 32989768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.